Similar articles for PMID: 31398192

Year	Number of Results
1990	1
1991	3
1992	1
1993	2
1994	2
1995	3
1996	6
1997	2
1998	1
1999	1
2000	2
2003	1
2005	2
2006	3
2008	2
2009	2
2010	1
2011	3
2012	4
2013	6
2014	2
2015	4
2016	6
2017	11
2018	7
2019	14
2020	15
2021	10
2022	10
2023	7
2024	0

1

Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function.

Ollé Hurtado M, Wolbert J, Fisher J, Flutter B, Stafford S, Barton J, Jain N, Barone G, Majani Y, Anderson J. Ollé Hurtado M, et al. PLoS One. 2019 Aug 9;14(8):e0216373. doi: 10.1371/journal.pone.0216373. eCollection 2019. PLoS One. 2019. PMID: 31398192 Free PMC article.

2

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.

Ye Q, Loisiou M, Levine BL, Suhoski MM, Riley JL, June CH, Coukos G, Powell DJ Jr. Ye Q, et al. J Transl Med. 2011 Aug 9;9:131. doi: 10.1186/1479-5876-9-131. J Transl Med. 2011. PMID: 21827675 Free PMC article.

3

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells.

Owens GL, Price MJ, Cheadle EJ, Hawkins RE, Gilham DE, Edmondson RJ. Owens GL, et al. Cancer Immunol Immunother. 2018 Oct;67(10):1519-1531. doi: 10.1007/s00262-018-2211-3. Epub 2018 Jul 23. Cancer Immunol Immunother. 2018. PMID: 30039427 Free PMC article.

4

Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.

Lee HJ, Kim YA, Sim CK, Heo SH, Song IH, Park HS, Park SY, Bang WS, Park IA, Lee M, Lee JH, Cho YS, Chang S, Jung J, Kim J, Lee SB, Kim SY, Lee MS, Gong G. Lee HJ, et al. Oncotarget. 2017 Dec 6;8(69):113345-113359. doi: 10.18632/oncotarget.23007. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371915 Free PMC article.

5

Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

Wu R, Forget MA, Chacon J, Bernatchez C, Haymaker C, Chen JQ, Hwu P, Radvanyi LG. Wu R, et al. Cancer J. 2012 Mar-Apr;18(2):160-75. doi: 10.1097/PPO.0b013e31824d4465. Cancer J. 2012. PMID: 22453018 Free PMC article. Review.

6

Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma.

Kataoka Y, Matsumura T, Yamamoto S, Sugimoto T, Sawada T. Kataoka Y, et al. Cancer Lett. 1993 Sep 15;73(1):11-21. doi: 10.1016/0304-3835(93)90182-9. Cancer Lett. 1993. PMID: 8402593

7

CTLA-4 blockade boosts the expansion of tumor-reactive CD8⁺ tumor-infiltrating lymphocytes in ovarian cancer.

Friese C, Harbst K, Borch TH, Westergaard MCW, Pedersen M, Kverneland A, Jönsson G, Donia M, Svane IM, Met Ö. Friese C, et al. Sci Rep. 2020 Mar 3;10(1):3914. doi: 10.1038/s41598-020-60738-4. Sci Rep. 2020. PMID: 32127601 Free PMC article.

8

Expansion of Tumor-Infiltrating CD8⁺ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy.

Fernandez-Poma SM, Salas-Benito D, Lozano T, Casares N, Riezu-Boj JI, Mancheño U, Elizalde E, Alignani D, Zubeldia N, Otano I, Conde E, Sarobe P, Lasarte JJ, Hervas-Stubbs S. Fernandez-Poma SM, et al. Cancer Res. 2017 Jul 1;77(13):3672-3684. doi: 10.1158/0008-5472.CAN-17-0236. Epub 2017 May 18. Cancer Res. 2017. PMID: 28522749

9

T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy.

Andersen R, Westergaard MCW, Kjeldsen JW, Müller A, Pedersen NW, Hadrup SR, Met Ö, Seliger B, Kromann-Andersen B, Hasselager T, Donia M, Svane IM. Andersen R, et al. Cancer Immunol Res. 2018 Feb;6(2):222-235. doi: 10.1158/2326-6066.CIR-17-0467. Epub 2018 Jan 4. Cancer Immunol Res. 2018. PMID: 29301752

10

Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.

Mulders P, Tso CL, Pang S, Kaboo R, McBride WH, Hinkel A, Gitlitz B, Dannull J, Figlin R, Belldegrun A. Mulders P, et al. J Immunother. 1998 May;21(3):170-80. doi: 10.1097/00002371-199805000-00002. J Immunother. 1998. PMID: 9610908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year